Which type of DNA technology is used to cause bacteria to produce human insulin?

The type of DNA technology used to cause bacteria to produce human insulin is recombinant DNA technology. In this process, the gene for human insulin is inserted into the genome of a bacterium, such as Escherichia coli (E. coli), using techniques such as restriction enzymes and ligase enzymes. Once the gene is inserted, the bacterium is then able to produce human insulin, which can be purified and used for medical purposes. This technology has revolutionized the production of insulin, making it more accessible and affordable for people with Diabetes. Recombinant DNA technology has also been used to produce many other human proteins, such as growth hormone and blood clotting factors, with great success.